Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors in dogs
Compose a Response to This Article
Other responses
No responses have been published for this article.
